subscribeSubscribe
GSK scraps plan to launch oral anemia drug beyond US, Japan

GSK scraps plan to launch oral anemia drug beyond US, Japan
Angus Liu FIERCE PHARMA
27 Jul 2023
Share Share
GSK receives positive CHMP opinion recommending authorisation of daprodustat

GSK receives positive CHMP opinion recommending authorisation of daprodustat
PRESS RELEASE
26 Jun 2023
Share Share
U.S. FDA approves GSK`s anemia drug for patients on dialysis

U.S. FDA approves GSK`s anemia drug for patients on dialysis
REUTERS
02 Feb 2023
Share Share
GSK reports outcome from US FDA Advisory Committee meeting on daprodustat for anaemia of CKD

GSK reports outcome from US FDA Advisory Committee meeting on daprodustat for anaemia of CKD
PRESS RELEASE
27 Oct 2022
Share Share
FDA raises safety questions with GSK`s potential CKD drug ahead of adcomm

FDA raises safety questions with GSK`s potential CKD drug ahead of adcomm
Zachary Brennan ENDPTS
26 Oct 2022
Share Share
GSK’s daprodustat will have to face FDA advisory committee

GSK’s daprodustat will have to face FDA advisory committee
PHARMAPHORUM
08 Sep 2022
Share Share
Could the third time be the charm for an oral anemia med at FDA?

Could the third time be the charm for an oral anemia med at FDA?
Fraiser Kansteiner FIERCEPHARMA
19 Apr 2022
Share Share
EMA accepts GSK’s MAA for daprodustat for treatment of anaemia of CKD

EMA accepts GSK’s MAA for daprodustat for treatment of anaemia of CKD
PHARMABIZ
02 Mar 2022
Share Share
GSK pulls off clean sweep of endpoint hits in anemia phase 3

GSK pulls off clean sweep of endpoint hits in anemia phase 3
N.P. Taylor FIERCEBIOTECH
09 Nov 2021
Share Share
Positive results for GSK’s anaemia drug daprodustat

Positive results for GSK’s anaemia drug daprodustat
Lucy Parsons PHARMATIMES
08 Nov 2021
Share Share